Platelet Rich Plasma Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 – 2030

The Global Platelet Rich Plasma Market Size accounted for USD 444.5 Million in 2021 and is estimated to garner a market size of USD 1,252.4 Million by 2030 rising at a CAGR of 12.3% from 2022 to 2030. The primary factor driving market growth is the increasing application in numerous medical procedures. In addition, growing application in cosmetic industry is a popular platelet rich plasma market trend that is driving the industry growth. PRP has the potential to grow in cosmetic surgery, with plastic surgeons and dermatologists utilizing the platelets' natural healing properties to improve the appearance and overall wellness of the skin

Platelet Rich Plasma PRP Market Report Key Highlights

• Global platelet rich plasma market revenue is estimated to reach USD 1,252.4 Million by 2030 with a CAGR of 12.3% from 2022 to 2030
• North America platelet rich plasma market share accounted for over 40% regional shares in 2021
• According to the WHO, till date 118.5 million blood donations are collected globally
• Asia-Pacific platelet rich plasma market growth will record fastest CAGR from 2022 to 2030
• Based on type segment, pure platelet-rich plasma (PRP) accounted 50% of the overall market share in 2021
• Growing prevalence of orthopedic disorders propels the platelet rich plasma market value in coming years

Platelet Rich Plasma (PRP) is a substance that promotes healing when injected with the help of cell regeneration. It’s a component of blood that contains special factors or proteins that help blood clotting. Moreover, PRP also contains proteins that support cell growth and are prepared by isolating plasma from blood and concentrating it. The injection of PRP into damaged tissues stimulates the body to grow new healthy cells and promotes healing. These have applications across hair loss, tendon injuries, acute injuries, postsurgical repair, and osteoarthritis.

Global Platelet Rich Plasma (PRP) Market Dynamics

Market Drivers

• Rise in the incidence of orthopedic disorders and sports injuries
• Growing number of cosmetic surgical procedures
• Increasing investment in PRP for hair loss treatment
• Rise in elderly population

Market Restraints

• High cost associated with PRP products
• Nerve injuries and tissue damage to the patients during surgeries

Market Opportunities

• Increasing regulatory focus on host cell contaminant detection
• Extending medical applications of platelet rich plasma

Platelet Rich Plasma Market Report Coverage

Market Dynamics

The rising incidence of orthopedic disorders and sports injuries is driving the market growth. The increasing number of cosmetic surgery procedures simultaneously extending medical applications of platelet rich plasma is propelling the market growth. The increasing number of evidence-based studies for PRP-based wound healing is further bolstering the market value. Furthermore, increasing breadth and use of PRP therapy across Medicare beneficiaries is expected to provide potential opportunities over the forecast period from 2022 to 2030. On the other side, high costs associated with PRP Origins are likely to hinder the growth over the forecast period from 2022 to 2030.

Platelet Rich Plasma Market Segmentation

The worldwide platelet rich plasma market is split based on type, origin, application, and geography.

Platelet Rich Plasma Market By Type

• Pure Platelet-Rich Plasma
• Leukocyte Platelet-Rich Plasma
• Pure Platelet-Rich Fibrin
• Leukocyte Platelet-Rich Fibrin

On the basis of type, pure platelet-rich plasma (PRP) has a potential share in terms of value in the global market. The pure PRP contains highly concentrated platelet growth factors with reduced red blood cells. Some of the advantages associated with the pure PRP include accelerated healing process, tissue repair and generation, and improvement in overall function that are factors projected to create demand over the forecast period from 2022 to 2030.

Platelet Rich Plasma Market By Origin

• Autologous Platelet-Rich Plasma
• Allogeneic Platelet-Rich Plasma
• Homologous Platelet-Rich Plasma

Platelet Rich Plasma Market By Application

• Cosmetic Surgery
• Orthopedic Surgery
• Ophthalmic Surgery
• Dentistry
• Cardiac Surgery
• Neurosurgery
• Others

Platelet Rich Plasma Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa

North America Platelet Rich Plasma Market Accounted For the Maximum Revenue Share in the Global Market

In 2021, North America held the major share owing to the presence of a high-income population and advance healthcare infrastructure. The major economies of the region including the US and Canada are the major revenue contributors to the regional platelet-rich plasma market. The increasing awareness about platelet-rich plasma treatments, the rising number of cosmetic surgeries, and the active involvement of academic and research institutes in evaluating the application of platelet-rich plasma therapies are boosting the regional market value. The increasing risk of sports injuries among young athletes is additionally expected to support growth over the forecast timeframe from 2022 to 2030. According to the U.S. Centers for Disease Control (CDC), the participation of individuals in sports in the U.S. is continuously rising and around 30 million children and adolescents in the U.S. participate in sports.

Asia-Pacific Platelet Rich Plasma Market Is Projected To Exhibit Fastest Growth over the Forecast Period from 2022 To 2030

Asia Pacific is anticipated to experience the fastest growth with a major CAGR (%) during the estimated period from 2022 to 2030. The rapidly developing economies of the region including China and India are the major revenue contributors to the regional market. The increasing investment in research and development (R&D) activities in order to provide more advance and effective solutions to the end-users are further projected to exhibit growth over the estimated period from 2022 to 2030.

Platelet Rich Plasma Market Players

The global platelet rich plasma companies profiled in the report include APEX Biologix, Arthrex, Inc., Celling BioSciences, Dr. PRP America, LLC, EmCyte Corporation, Glofinn Oy, Johnson & Johnson (DePuy Synthes), Juventix, Stryker, T-Biotechnology (T-LAB), Terumo BCT, Inc., and Zimmer Biomet.